Mast Cell Activation Syndrome Explained

Mast Cell Activation Syndrome (MCAS): Symptoms, Causes, and Treatment

Mast Cell Activation Syndrome (MCAS) is an immune system condition that can cause a wide range of symptoms affecting multiple organs throughout the body. Many patients experience symptoms for years before receiving a diagnosis because the condition can mimic allergies, gastrointestinal disorders, and autonomic nervous system conditions.

At Galene Health Clinic, we frequently evaluate patients with complex chronic illnesses including mast cell activation syndrome, POTS (postural orthostatic tachycardia syndrome), and hypermobility disorders.

This article explains:

• What mast cell activation syndrome is

• Common MCAS symptoms

• The underlying pathophysiology

• Current treatment approaches

  
  

What Is Mast Cell Activation Syndrome?

Mast Cell Activation Syndrome (MCAS) is a disorder in which mast cells release excessive amounts of inflammatory chemicals called mediators. These substances include:

• Histamine

• Prostaglandins

• Leukotrienes

• Cytokines

• Tryptase

  
  

Mast cells are immune cells located throughout the body, particularly in tissues that interact with the environment such as the skin, respiratory tract, and gastrointestinal tract. Their normal role is to help the body respond to infections and allergic triggers.

In MCAS, mast cells become overly reactive and release inflammatory mediators inappropriately, leading to episodic symptoms affecting multiple body systems.

MCAS is typically classified into three categories:

Primary (clonal) MCAS

Associated with abnormal mast cells, sometimes related to mastocytosis.

Secondary MCAS

Triggered by another condition such as allergies, infections, or autoimmune disease.

Idiopathic MCAS

No clear cause can be identified.

Common Symptoms of Mast Cell Activation Syndrome

Because mast cells exist throughout the body, MCAS can produce symptoms in many organ systems simultaneously.

Skin Symptoms

• Flushing

• Hives (urticaria)

• Itching

• Angioedema (swelling of lips, eyelids, or face)

  
  

Gastrointestinal Symptoms

• Abdominal pain

• Diarrhea or constipation

• Nausea and vomiting

• Bloating

  
  

Cardiovascular Symptoms

• Lightheadedness

• Low blood pressure

• Rapid heart rate

• Fainting or near-syncope

  
  

Respiratory Symptoms

• Wheezing

• Shortness of breath

• Nasal congestion

  
  

Neurologic and Systemic Symptoms

• Brain fog

• Fatigue

• Headaches

• Temperature sensitivity

  
  

Many patients with MCAS also have related conditions such as:

• Postural orthostatic tachycardia syndrome (POTS)

• Ehlers-Danlos syndrome (EDS)

• Chronic fatigue or dysautonomia

• 
  

In severe cases, mast cell activation can cause anaphylaxis, which requires emergency treatment.

The Pathophysiology of MCAS

The hallmark of mast cell activation syndrome is abnormal mast cell activation and mediator release.

Normally, mast cells respond to specific triggers such as allergens or infections. When activated, they release inflammatory mediators through a process called degranulation.

In MCAS, mast cells may activate through several mechanisms:

IgE-Mediated Activation

This pathway resembles traditional allergic reactions, where allergens bind to IgE antibodies on mast cells and trigger mediator release.

Non-IgE Immune Activation

Mast cells can also be activated by:

• Complement proteins

• Cytokines

• Autoimmune signaling

• Microbial receptors such as toll-like receptors

  
  

Direct Mast Cell Activation

Certain stimuli can directly activate mast cells without an allergic pathway, including:

• Stress

• Temperature changes

• Alcohol

• Certain medications

• Infections

  
  

When mast cells release mediators such as histamine, prostaglandins, and leukotrienes, they cause inflammation, blood vessel dilation, nerve stimulation, and gastrointestinal motility changes, which explain the wide range of MCAS symptoms.

How Mast Cell Activation Syndrome Is Diagnosed

Diagnosing MCAS requires careful evaluation of the following:

1. Recurrent symptoms involving multiple organ systems consistent with mast cell mediator release

2. Laboratory evidence of mast cell activation, such as elevated serum tryptase or other mediator markers

3. Clinical improvement with medications that block mast cell mediators

Additional testing may include:

• Blood tryptase levels

• Urinary prostaglandin or histamine metabolites

• Evaluation for mastocytosis

• Genetic testing in some cases

Because MCAS symptoms overlap with many other conditions, diagnosis often requires evaluation by clinicians experienced in mast cell disorders.

Treatment Options for Mast Cell Activation Syndrome

Treatment focuses on reducing mast cell activation and blocking the effects of released mediators. Management plans are individualized based on symptoms.

Antihistamines

Antihistamines block histamine receptors and are often first-line therapy.

Examples include:

• Cetirizine

• Loratadine

• Famotidine (H2 blocker)

Mast Cell Stabilizers

These medications help prevent mast cells from releasing mediators.

Examples include:

• Cromolyn sodium

• Ketotifen

Leukotriene Inhibitors

Leukotriene inhibitors can reduce inflammatory signaling related to mast cell activation.

Example:

• Montelukast

Biologic Therapies

In some patients, biologic medications targeting allergic pathways may be helpful.

Emergency Treatment

Patients who experience severe reactions may require epinephrine auto-injectors to treat anaphylaxis.

Trigger Identification and Lifestyle Management

Common triggers include:

• Alcohol

• Certain foods

• Stress

• Temperature extremes

• Infections

• Certain medications

Avoiding known triggers can significantly reduce symptoms.

When to See a Specialist for MCAS

If you experience symptoms such as recurrent flushing, unexplained allergic reactions, dizziness, gastrointestinal issues, or chronic fatigue, it may be helpful to seek evaluation from a clinician familiar with mast cell disorders.

At Galene Health Clinic, we specialize in evaluating complex conditions including:

• Mast cell activation syndrome (MCAS)

• Dysautonomia and POTS

• Ehlers-Danlos syndrome

• Chronic immune-mediated illnesses

If you suspect mast cell activation may be contributing to your symptoms, a comprehensive medical evaluation can help determine the best treatment approach.

References

Akin, C., Valent, P., & Metcalfe, D. D. (2010). Mast cell activation syndrome: Proposed diagnostic criteria. Journal of Allergy and Clinical Immunology, 126(6), 1099–1104. https://pubmed.ncbi.nlm.nih.gov/21035176/

Castells, M., Giannetti, M. P., Hamilton, M. J., & Novak, P. (2024). Mast cell activation syndrome: Current understanding and research needs. Journal of Allergy and Clinical Immunology, 154(2), 255–263. https://pubmed.ncbi.nlm.nih.gov/38851398/

Cleveland Clinic. (2024). Mast cell activation syndrome (MCAS). Retrieved from https://my.clevelandclinic.org/health/diseases/mast-cell-activation-syndrome

Valent, P., Akin, C., & Arock, M. (2020). Diagnosis, classification and management of mast cell activation disorders. International Journal of Molecular Sciences, 21(23), 9030. https://pubmed.ncbi.nlm.nih.gov/33261124/

Weiler, C. R., et al. (2019). Mast cell activation syndrome: Tools for diagnosis and management. Journal of Allergy and Clinical Immunology: In Practice, 7(4), 1099–1106.

https://pubmed.ncbi.nlm.nih.gov/31470118/